Skip to main navigation
Invivyd
  • About Us
    • Management Team
    • Board of Directors
  • Our Approach
    • Coronaviruses Background
    • Pipeline
    • Publications
  • Clinical Trials
  • Investors & Media
  • Partners
  • Careers
  • Contact
  • About Us
    • Management Team
    • Board of Directors
  • Our Approach
    • Coronaviruses Background
    • Pipeline
    • Publications
  • Clinical Trials
  • Investors & Media
  • Partners
  • Careers
  • Contact
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

SEC Filing Details

Document Details

Form
4
Filing Date
Jun 24, 2022
Document Date
Jun 24, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Invivyd
Issuer
INVIVYD, INC.
Filer
HEYMAN TOMAS J.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Invivyd

For general inquiries:
info@invivyd.com

For medical information
inquiries:
medinfo@invivyd.com

781-819-0080

  • Follow
  • Follow

1601 Trapelo Rd.
Suite 178
Waltham, MA 02451

Privacy Policy   |   Terms of Use   |   Cookie Policy